---
schema_version: "secwatch.filing_event.v1"
accession: "0000784199-23-000130"
form_type: "8-K"
ticker: "AORT"
cik: "0000784199"
company_name: "ARTIVION, INC."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T10:15:21.362126+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Artivion Q2 revenue $89.3M (+11% YoY); raises FY revenue guidance to $342-350M

## Summary
- Net loss ($3.4M) or ($0.08)/share; non-GAAP net income $2.3M ($0.06)/share.
- Non-GAAP adjusted EBITDA $13.8M, up 35% YoY.
- Aortic stent graft revenue +19% YoY; On-X +11% constant currency.
- Received $14.3M PerClot PMA approval milestone payment from Baxter.
- FY 2023 constant currency revenue growth guidance raised to 10%-12%.

## SEC filing metadata
- accession: 0000784199-23-000130
- form_type: 8-K
- ticker: AORT
- cik: 0000784199
- company_name: ARTIVION, INC.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/0000784199-23-000130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/aort-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000784199-23-000130
- JSON: https://secwatch.observer/filing/0000784199-23-000130.json
- Plain text: https://secwatch.observer/filing/0000784199-23-000130.txt

## Key facts
- Earnings Releases
  ARTIVION, INC. reported the second quarter ended June 30, 2023 results: revenue $89.3 million, net income ($3.4) million, EPS ($0.08) per share. Guidance raised.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $89.3 million
  - Net income: ($3.4) million
  - EPS: ($0.08) per share
  - Guidance: raised
  - Result: reported results
  source text: • Achieved revenue of $89.3 million in the second quarter of 2023 versus $80.3 million in the second quarter of 2022, an increase of 11% on both a GAAP and non-GAAP constant currency basis • Net loss was ($3.4) million or ($0.08) per share;
  evidence_url: https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/0000784199-23-000130-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.